Mar 6, 2026 09:26AM Jones Trading Downgrades Day One Biopharmaceuticals (DAWN) to Hold following sale to Servier

Mar 6, 2026 08:31AM Servier to acquire Day One Biopharmaceuticals for $2.5 billion

Mar 6, 2026 08:26AM Day One Biopharmaceuticals (DAWN) Halted, News Pending

Feb 25, 2026 07:11AM Day One Biopharmaceuticals (DAWN) PT Lowered to $17 at Needham

Feb 25, 2026 06:41AM Day One Biopharmaceuticals (DAWN) PT Lowered to $22 at H.C. Wainwright

Feb 24, 2026 04:06PM Day One Biopharmaceuticals, Inc. (DAWN) reported Q4 Revenue ; Offers Guidance

Jan 22, 2026 06:24AM Increasing unusual put option volume: EWC XLB LW CRVS XP ASO CHPT DAWN IBRX

Jan 20, 2026 02:42PM Day One Biopharmaceuticals (DAWN) 22K contracts of April 11 calls trade as share price up 15.4%

Jan 20, 2026 09:53AM Increasing unusual option volume: GTM CRVS IBRX DAWN PRGO RVMD EWG

Jan 13, 2026 05:01AM TD Cowen Starts Day One Biopharmaceuticals (DAWN) at Buy

Jan 12, 2026 04:04AM Day One Biopharmaceuticals reports 2025 revenue of $155.4 million

Dec 22, 2025 10:11AM Increasing unusual option volume: HNRG FOXA CWAN RSI PLCE VIPS LW DAWN

Dec 22, 2025 05:36AM Increasing unusual option volume: STT WOLF LW EWC OIH GDXJ DAWN

Dec 18, 2025 11:09AM Increasing unusual option volume: JBL DAWN PYXS NVT SEI PENG VRNS SBIT FLWS

Nov 25, 2025 06:54AM H.C. Wainwright Reiterates Buy Rating on Day One Biopharmaceuticals (DAWN)

Nov 10, 2025 04:16AM Day One Biopharmaceuticals (DAWN) December 10 and 11 calls active

Nov 4, 2025 04:03PM Day One Biopharmaceuticals, Inc. (DAWN) Tops Q3 EPS by 10c

Sep 26, 2025 06:48AM H.C. Wainwright Reiterates Buy Rating on Day One Biopharmaceuticals (DAWN)

Aug 19, 2025 06:15AM Piper Sandler Starts Day One Biopharmaceuticals (DAWN) at Overweight

Jun 10, 2025 08:31AM Day One Biopharmaceuticals (DAWN) Appoints Michael Vasconcelles, M.D., as Head of Research and Development

Jun 2, 2025 06:53AM H.C. Wainwright Reiterates Buy Rating on Day One Biopharmaceuticals (DAWN)

May 12, 2025 09:05AM TD Cowen on Day One Biopharmaceuticals (DAWN): 'Focused Approach Could Lead to Double-Digit Growth'

May 6, 2025 05:13PM Day One Biopharmaceuticals, Inc. (DAWN) Tops Q1 EPS by 7c

Apr 3, 2025 06:49AM H.C. Wainwright Reiterates Buy Rating on Day One Biopharmaceuticals (DAWN)

Feb 26, 2025 06:48AM Day One Biopharmaceuticals (DAWN) PT Lowered to $36 at H.C. Wainwright

Jan 13, 2025 08:15AM Day One Biopharmaceuticals (DAWN) Reports Preliminary 2024 OJEMDA Net Product Revenue and Highlights 2025 Corporate Priorities

Nov 20, 2024 04:30PM Day One Biopharmaceuticals (DAWN) Announces Retirement of Dr. Samuel Blackman, Co-Founder and Head of Research & Development

Nov 19, 2024 11:00AM JPM just added these stocks to its Analyst Focus List - giving one 148% upside

Oct 31, 2024 07:59AM H.C. Wainwright Reiterates Buy Rating on Day One Biopharmaceuticals (DAWN)

Oct 23, 2024 07:21AM Piper Sandler Reiterates Overweight Rating on Day One Biopharmaceuticals (DAWN)

Oct 9, 2024 07:18AM Day One Biopharmaceuticals (DAWN) PT Raised to $33 at Needham

Aug 12, 2024 04:44PM Goldman Sachs Reiterates Buy Rating on Day One Biopharmaceuticals (DAWN)

Jul 30, 2024 07:01AM Day One Biopharmaceuticals (DAWN) Announces 10.55M Share Offering at $14.50/sh

Jul 8, 2024 07:47AM Piper Sandler Reiterates Overweight Rating on Day One Biopharmaceuticals (DAWN)